Tumor microenvironment–targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors
Science Advances · 05.12.2025 · 11 (49)
DOI: 10.1126/sciadv.adu2292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.12.2025. Verfasst von Kristen C Vogt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nanoparticles, Proteolysis, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Proteolysis-targeting chimeras (PROTACs) are catalytic protein degraders with promising preclinical activity. The clinical translation of PROTACs has been limited by poor pharmacologic properties and toxicities, in part due to their “non-druglike” characteristics, including large molecular weights. We found that the vast majority of PROTACs can self-assemble into nanoparticles, yielding nanoparticle PROTACs (nanoPROTACs) with ultrahigh drug loadings. While PROTAC molecular features can be deleterious to their pharmacokinetic properties, we found that they can drive nanoencapsulation more efficiently than FDA-approved small-molecule drugs. Using structure-based prediction algorithms, we identified spatial autocorrelation molecular descriptors that defined nanoPROTAC formation with 96% sensitivity at 100% specificity. NanoPROTACs, targeted to the tumor microenvironment via P-selectin, led to significantly enhanced tumor drug uptake, target degradation, tumor growth inhibition, and overall survival in solid tumor xenografts. These findings offer a broad strategy to improve the pharmacologic properties and therapeutic index of PROTACs and potentially other non-druglike experimental therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.
- Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Departments of Neurosciences and Pediatrics, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Kristen C Vogt, Magdalini Panagiotakopoulou, Mandana T Manzari Honu, Ana Marie Perea, Xiaoping Hu, Xufen Yu, Stephen Ruiz, G Praveen Raju, Jian Jin, David A Scheinberg, Daniel A Heller
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- NIH HHS
- National Science Foundation
- National Institutes of Health
- NINDS
- MSKCC MERIT Graduate Fellowship
Zitieren
APA
Vogt, K. C., Panagiotakopoulou, M., Manzari Honu, M. T., Perea, A. M., Hu, X., Yu, X., Raziuddin, R., LaPlant, Q., Ruiz, S., Raju, G. P., Jin, J., Scheinberg, D. A., & Heller, D. A. (2025). Tumor microenvironment–targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors. Science Advances, 11(49). https://doi.org/10.1126/sciadv.adu2292
Vancouver
Vogt KC, Panagiotakopoulou M, Manzari Honu MT, Perea AM, Hu X, Yu X, et al. Tumor microenvironment–targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors. Science Advances. 2025;11(49). doi:10.1126/sciadv.adu2292
BibTeX
@article{Vogt2025,
author = {Vogt, Kristen C and Panagiotakopoulou, Magdalini and Manzari Honu, Mandana T and Perea, Ana Marie and Hu, Xiaoping and Yu, Xufen and Raziuddin, Raashed and LaPlant, Quincey and Ruiz, Stephen and Raju, G Praveen and Jin, Jian and Scheinberg, David A and Heller, Daniel A},
title = {Tumor microenvironment–targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {49},
doi = {10.1126/sciadv.adu2292}
}
EUVIMED